These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36941023)

  • 1. Quality of life and productivity loss in patients with ankylosing spondylitis using tumor necrosis factor inhibitors.
    Ma KS; Kao PE; Chen KH; Liu CH
    Int J Rheum Dis; 2023 Jul; 26(7):1412-1413. PubMed ID: 36941023
    [No Abstract]   [Full Text] [Related]  

  • 2. Personalized tapering of tumor necrosis factor inhibitor in axial spondyloarthritis.
    Huang JX; Lee YH; Leong PY; Wei JC
    Int J Rheum Dis; 2024 Jan; 27(1):e15008. PubMed ID: 38140850
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross-sectional observational study.
    Lee SH; Kim YG; Lee SG; Lee SH; Kim YJ; Jeon JY; Jo JY; Yoo HJ; Lee J; Kim TH
    Int J Rheum Dis; 2022 May; 25(5):523-531. PubMed ID: 35187866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Safety Profile of Tumor Necrosis Factor Inhibitors in Ankylosing Spondylitis: Are TNF Inhibitors Safer Than We Thought?
    Wroński J; Fiedor P
    J Clin Pharmacol; 2019 Apr; 59(4):445-462. PubMed ID: 30476367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polychondritis in a Patient With Ankylosing Spondylitis on an Anti-TNF-α Biosimilar Agent.
    Duro T; Li S; Jose D; Khawar T
    J Clin Rheumatol; 2021 Dec; 27(8S):S656. PubMed ID: 35073638
    [No Abstract]   [Full Text] [Related]  

  • 6. Is low-dose tumor necrosis factor inhibitor effective and safe in patients with ankylosing spondylitis flare-up after renal transplantation? A case report and literature review.
    Leong PY; Shih PC; Huo AP
    Int J Rheum Dis; 2024 Jan; 27(1):e14877. PubMed ID: 37602749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and safety of anti-TNF therapy for ankylosing spondylitis: a real-world study.
    Kömel Pimenta PR; Ribeiro da Silva MR; Ribeiro Dos Santos JB; Kakehasi AM; Assis Acurcio F; Alvares-Teodoro J
    J Comp Eff Res; 2021 Apr; 10(6):509-517. PubMed ID: 33728937
    [No Abstract]   [Full Text] [Related]  

  • 8. Palmoplantar pustulosis secondary to anti-tumor necrosis factor therapy in a patient with ankylosing spondylitis.
    Bae JM; Eun SH; Kim KJ
    Korean J Intern Med; 2020 Jan; 35(1):254-255. PubMed ID: 31623028
    [No Abstract]   [Full Text] [Related]  

  • 9. Secukinumab can treat psoriasis induced by anti-TNF-alpha therapy in patients with ankylosing spondylitis: Case series.
    Apaydin H; Dogan I; Erten Ş
    Int J Rheum Dis; 2020 Mar; 23(3):454-456. PubMed ID: 31945270
    [No Abstract]   [Full Text] [Related]  

  • 10. Correspondence on 'Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence'.
    Zhang ZL; Huang W; Lv GH; Li J; Zou MX; Dai ZH
    Ann Rheum Dis; 2022 Dec; 81(12):e252. PubMed ID: 33004326
    [No Abstract]   [Full Text] [Related]  

  • 11. Response to 'Correspondence on "Tumour necrosis factor inhibitors slow radiographic progression in patients with ankylosing spondylitis: 18-year real-world evidence" by Zhang
    Koo BS; Oh JS; Park SY; Shin JH; Ahn GY; Lee S; Joo KB; Kim TH
    Ann Rheum Dis; 2022 Dec; 81(12):e253. PubMed ID: 33004327
    [No Abstract]   [Full Text] [Related]  

  • 12. TNF inhibitors for ankylosing spondylitis in the real world.
    McVeigh CM; Bell AL; Cairns AP
    Rheumatol Int; 2007 Dec; 28(2):199-200. PubMed ID: 17602229
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment with golimumab or infliximab reduces health resource utilization and increases work productivity in patients with ankylosing spondylitis in the QUO-VADIS study, a large, prospective real-life cohort.
    Claudepierre P; Van den Bosch F; Sarzi-Puttini P; Vastesaeger N; Govoni M; Kachroo S
    Int J Rheum Dis; 2019 Jun; 22(6):995-1001. PubMed ID: 30989813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha.
    Gorman JD; Sack KE; Davis JC
    N Engl J Med; 2002 May; 346(18):1349-56. PubMed ID: 11986408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Scrotal pain of a patient with ankylosing spondylitis successfully treated with TNF-alpha inhibitor: a case report.
    Suzuki H; Tsujimoto T; Ota M; Hasegawa Y; Oha F; Shimamura Y; Tanaka M; Hashimoto T; Iwasaki N; Kanayama M
    J Orthop Sci; 2024 Jan; 29(1):402-404. PubMed ID: 35690543
    [No Abstract]   [Full Text] [Related]  

  • 16. BSR guidelines for prescribing TNF-alpha blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology.
    Keat A; Barkham N; Bhalla A; Gaffney K; Marzo-Ortega H; Paul S; Rogers F; Somerville M; Sturrock R; Wordsworth P;
    Rheumatology (Oxford); 2005 Jul; 44(7):939-47. PubMed ID: 15901904
    [No Abstract]   [Full Text] [Related]  

  • 17. Group classification of medication using and validity of ankylosing spondylitis diagnosis.
    Chang HC; Gau SY
    Pharmacol Res; 2022 Nov; 185():106465. PubMed ID: 36162601
    [No Abstract]   [Full Text] [Related]  

  • 18. Liver enzyme elevation in patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors: a single-center historical cohort study.
    Choi SJ; Oh JS; Hong S; Lee CK; Yoo B; Kim YG
    Korean J Intern Med; 2020 May; 35(3):723-731. PubMed ID: 31870134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cost per responder analysis of secukinumab vs adalimumab for the treatment of ankylosing spondylitis from the Korean perspective.
    Kim D; Kim H; Cho S; Park MC
    Int J Rheum Dis; 2019 Sep; 22(9):1630-1637. PubMed ID: 31215166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring patients with ankylosing spondylitis on anti-TNF monotherapy: too much too often?
    Gunasekera W; Creamer P; Creamer K; Sengupta R
    Scand J Rheumatol; 2017 Jul; 46(4):330-331. PubMed ID: 27733090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.